ZyVersa Therapeutics, Inc. (ZVSA) research

ZyVersa Therapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$0.08
As of

ZyVersa Therapeutics, Inc. (ZVSA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-16.

As of . Source: SEC EDGAR filings for ZVSA. Method and limitations.

SHARE THIS CARD

Share the ZVSA intelligence card

A branded snapshot of ZVSA: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ZVSA intelligence card preview
Post to X
COMPANY DOSSIER

See the full ZVSA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ZVSA on one page. Preview it with sample data, then open it live with a free account.

Preview the ZVSA dossier

Active signals for ZVSA

FREE, NO ACCOUNT

Every signal on ZVSA, as it fires

You are seeing 5 of 6 signals recorded on ZVSA since 2026-05-31.

The five above landed across 2 days. The other 1 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, ZVSA

Related tickers

See more ZVSA signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ZVSAand get the insider, 13F, options, and confluence read in one view.

Preview the ZVSA dossier